INS and sarcopenia: The presumed protective role of metformin in relation to sarcopenia may be explained by some possible actions of this drug such as the effect on insulin sensitivity—involved in the uptake of glucose and calcium in skeletal muscles [121]—and the reduction of inflammation and oxidative stress, which may lead to an improvement of muscle quality and strength [122,123].